Pei-Wen Lee et al | 20 Jan 2010 | Malaria Journal
Plasmodium falciparum is the major species responsible for malaria transmission on the island of Principe, in the Republic of Sao Tome and Principe (STP). Indoor residual spraying (IRS) has been intensively deployed on the island, since 2003.
Chandy C. John et al | 08 Dec 2009 | Emerging Infectious Diseases
Highland areas where malaria transmission is unstable are targets for malaria elimination because transmission decreases to low levels during the dry season. In highland areas of Kipsamoite and Kapsisiywa, Kenya, annual household IRS with a
synthetic pyrethroid was performed starting in 2005, and
artemether/lumefantrine was implemented as first-line malaria treatment
in October 2006.
None | 15 Jun 2009 | World Health Organization
The twelfth meeting of the WHOPES Working Group, an advisory group to the WHO Pesticide Evaluation Scheme (WHOPES), was convened at WHO headquarters in Geneva, Switzerland, from 8 to 11 December 2008.
Pascalina Chanda et al | 17 Mar 2009 | Malaria Journal
Malaria related OPD visits have reduced at Chongwe rural health facility. The reduction in health facility malaria cases has led to an increase in diagnoses of respiratory infections. These findings have implications for the management of non-malaria fevers in children under the age of five years.
Roger Bate & Karen Porter | 29 Jan 2009 | American Enterprise Institute
The World Health Organization (WHO) launched the International Medical Products Anti-Counterfeiting Taskforce (IMPACT) in 2006 to combat the global problem of counterfeit pharmaceuticals, which kill untold thousands of people every year.
World Malaria Report 2008
None | 18 Sep 2008 | World Health Organization
Half of the world's population is at risk of malaria, and an estimated 247 million cases led to nearly 881 000 deaths in 2006. The World malaria report 2008 describes the global distribution of cases and deaths, how WHO-recommended control strategies have been adopted and implemented in endemic countries, sources of funding for malaria control, and recent evidence that prevention and treatment can alleviate the burden of disease.
Emmanuel Chanda et al | 27 Aug 2008 | Malaria Journal
The Zambian Malaria Control Programme with the Roll Back Malaria (RBM) partners have developed the current National Malaria Strategic Plan (NMSP 2006-2011) which focuses on prevention based on the Integrated Vector Management (IVM) strategy. The introduction and implementation of an IVM strategy was planned in accordance with the World Health Organization (WHO) steps towards IVM implementation namely Introduction Phase, Consolidation Phase and Expansion Phase.
Annette AM Gerritsen, Philip Kruger, Maarten F Schim van der Loeff & Martin P Grobusch | 25 Aug 2008 | Malaria Journal
Malaria is endemic in the low-altitude areas of the northern and eastern parts of South Africa with seasonal transmission. The aim of this descriptive study is to give an overview of the malaria incidence and mortality in Limpopo Province for the seasons 1998-1999 to 2006-2007 and to detect trends over time and place.
Robert W. Snow, Carlos A. Guerra, Juliette J. Mutheu & Simon I. Hay | 22 Jul 2008 | PloS Medicine
The international financing of malaria control has increased significantly in the last ten years in parallel with calls to halve the malaria burden by the year 2015. The allocation of funds to countries should reflect the size of the populations at risk of infection, disease, and death. To examine this relationship, we compare an audit of international commitments with an objective assessment of national need: the population at risk of stable Plasmodium falciparum malaria transmission in 2007.
Richard Feachem & Oliver Sabot | 27 Mar 2008 | The Lancet
On Oct 17, 2007, Bill and Melinda Gates called for complete eradication to be adopted as the new goal for the age-old fight against malaria, with the Director General of WHO, Margaret Chan, promptly echoing their conviction. Although debate over the wisdom of this target will continue, growing impatience with the low ambitions of current efforts, fuelled by reductions in morbidity and mortality in some countries and progress in the development of new drugs and the first-ever vaccine, will lead many decision makers to adopt eradication of malaria as the primary aim for their organisations.